Silencing Bcl-2 Expression in Epithelial Cancer Cells Using “Smart” Particles
Source abstract
Abstract
Short interfering RNA (siRNA) targeted against anti-apoptotic Bcl-2 protein proved to knockdown its expression and trigger cancer cell death. We used degradable, pH-sensitive, comb-like [P(EAA-co-BMA)-b-PNASI-g-P(HMA-co-TMAEMA)] polymer to condense anti-Bcl-2 siRNA into “smart” particles, which proved to shuttle their cargo past the endosomal membrane and into the cytoplasm of HeLa and UM-SCC-17B cancer cells. HeLa and UM-SCC-17B cancer cells were treated with anti-Bcl-2 particles followed by quantifying Bcl-2 mRNA and protein levels using qRT-PCR and western blotting, respectively. “Smart” anti-Bcl-2 particles selectively suppress Bcl-2 mRNA and protein levels in HeLa cells by 50%–60% and 79%–81%, respectively. Similarly, “smart” anti-Bcl-2 particles inhibited Bcl-2 mRNA levels by 30%, 40%, and 20% upon incubation with UM-SCC-17B cancer cells for 48, 72, and 96 h, respectively. Bcl-2 protein expression in UM-SCC-17B cancer cells was inhibited by 30% after treatment for 72 h. Results show that pH-sensitive comb-like polymer complex anti-Bcl-2 siRNA forming “smart” nanoparticles that deliver their cargo into the cytoplasm of HeLa and UM-SCC-17B cancer cells causing Bcl-2 knockdown at the mRNA and protein levels.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Cell death mechanisms and regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, University of Michigan, 1101 Beal Ave., Ann Arbor, MI 48109, USA
Department of Cariology, Restorative Sciences, and Endodontics, University of Michigan, 1011 N. University Ave., Ann Arbor, MI 48109, USA
Macromolecular Science and Engineering Program, University of Michigan, 2300 Hayward Ave., Ann Arbor, MI 48109, USA
References (30)
Show source-provided references
1. The Bcl-2 protein family: Arbiters of cell survival10.1126/science.281.5381.1322 ↗
2. The Bcl-2 apoptotic switch in cancer development and therapy10.1038/sj.onc.1210220 ↗
3. Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma10.2174/157489211793980042 ↗
4. Mechanisms of apoptosis avoidance in cancer10.1097/00001622-199901000-00014 ↗
5. Dysregulation of apoptosis in cancer10.1200/JCO.1999.17.9.2941 ↗
6. Apoptosis in cancer: Cause and cure10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4 ↗
7. Bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy
8. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers10.1002/hed.20059 ↗
9. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth10.1158/0008-5472.CAN-07-1497 ↗
10. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy10.4161/cbt.4.7.1783 ↗
11. Degradable, ph-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acids10.1016/j.biomaterials.2010.05.048 ↗
12. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs10.1016/j.jconrel.2003.06.001 ↗
13. Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics10.1016/j.jconrel.2004.08.032 ↗
14. Alkylcarboxylate grafting to polyethylenimine: A simple approach to producing a DNA nanocarrier with low toxicity10.1002/jgm.1374 ↗
15. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector10.1021/bc800428y ↗
16. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
17. Effect of cell-surface glycosaminoglycans on cationic carrier combined with low-MW PEI-mediated gene transfection10.1016/j.ijpharm.2004.07.023 ↗
18. PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility10.1016/j.ijpharm.2003.12.029 ↗
19. Revisit the complexation of PEI and DNA—How to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure?10.1016/j.jconrel.2009.07.009 ↗
20. Evaluation of polyplexes as gene transfer agents10.1016/S0168-3659(01)00357-1 ↗
21. Theoretical considerations on the role of membrane potential in the regulation of endosomal pH10.1016/S0006-3495(97)78102-5 ↗
22. Regulation of endocytic ph by the Na+,K+-ATPase in living cells10.1073/pnas.86.2.544 ↗
23. Role of organelle pH in tumor cell biology and drug resistance10.1016/S1359-6446(98)01276-8 ↗
24. A new approach for enhancing differential selectivity of drugs to cancer cells10.1021/cb6001202 ↗
25. Organelle acidification and disease10.1034/j.1600-0854.2003.40201.x ↗
26. The mechanism of selective transfection mediated by pentablock copolymers; Part I: Investigation of cellular uptake10.1016/j.actbio.2010.11.032 ↗
27. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis
28. Poly(2-ethylacrylic acid)
29. Functional polymers from novel carboxyl-terminated trithiocarbonates as highly efficient raft agents10.1021/ma020362m ↗
30. Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling10.1593/neo.09266 ↗